CareLit Fachartikel
Efficacy of etrasimod at Week 52 among patients with clinical response at Week 12 compared with the overall ulcerative colitis population: post hoc analysis of the phase 3 ELEVATE…
B. Siegmund, S. Vermeire, B. E. Sands, M. C. Dubinsky, B. G. Feagan, R. Panaccione, V. Jairath, A. Yarur, M. Chiorean, J. Panés, M. Goetsch, C. J. Rabbat, P. Shah, J. Wu, S. Ghosh · Zeitschrift für Gastroenterologie · 2023 · Heft 08 · S. e415-e416
Dokument
888622
CareLit-ID
Jahr
2023
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Efficacy of etrasimod at Week 52 among patients with clinical response at Week 12 compared with the overall ulcerative colitis population: post hoc analysis of the phase 3 ELEVATE UC 52 trial
Schlagworte
Population
Zeitschrift für Gastroenterologie